MedTrace Logo

Lipoprotein a Assessment and Relation to Ca Score in CAD Patients Using MSCT

NCT07184034 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-09-19

No results posted yet for this study

Summary

The goal of this observational study is to evaluate whether serum Lipoprotein(a) \[Lp(a)\] levels are associated with coronary artery calcium (CAC) score measured by multi-slice computed tomography (MSCT) in adults undergoing cardiac risk assessment.

The main questions it aims to answer are:

* Is there a correlation between elevated Lp(a) levels and higher CAC scores?
* Does Lp(a) provide additional predictive value for subclinical atherosclerosis beyond traditional cardiovascular risk factors?

Participants will:

* Undergo a non-contrast MSCT scan to measure CAC score.
* Provide a blood sample for measurement of Lp(a) and routine lipid profile.
* Have baseline clinical and demographic data collected, including cardiovascular risk factors.

Conditions

  • Coronary Artery Disease (CAD)

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-09-30
Completion
2026-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07184034 on ClinicalTrials.gov